Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Meta-analysis of prevalence.
Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Mobility, Walking And Physical Activity In Persons With Multiple Sclerosis.
Abnormal brain iron metabolism in irp2 deficient mice is associated with mild neurological and behavioral impairments.
Self-intermittent catheterization in multiple sclerosis.
DSM-III disorders from age 11 to age 15 years.
Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.
Magnetic resonance imaging in neuromyelitis optica.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.
The squares test as a measure of hand function in multiple sclerosis.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.
The activities and participation categories of the ICF Core Sets for multiple sclerosis from the patient perspective.
Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson's and other brain diseases.
Biological insights from 108 schizophrenia-associated genetic loci.
No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Optic neuritis: A blurry issue.
Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
Future MRI tools in multiple sclerosis.
An unusual case of neurobrucellosis presenting as demyelination disorder.
Pain and spinal cord imaging measures in children with demyelinating disease.
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Pages
« first
‹ previous
…
364
365
366
367
368
369
370
371
372
…
next ›
last »